1. Research Objectives and Assumptions

   • Research Objectives
   • Assumptions
   • Abbreviations

2. Market Purview

   • Report Description
     • Market Definition and Scope
   • Executive Summary
     • Market Snapshot, By Drug Type
     • Market Snapshot, By Route of Administration
     • Market Snapshot, By Distribution Channel
     • Market Snapshot, By Region
   • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

   • Market Dynamics
     • Drivers
     • Restraints
     • Market Opportunities
   • Impact Analysis
   • Market Trends
   • Key Developments
   • Product Approval
   • Collaboration/Merge/Acquisition
   • Regulatory Landscape
   • PEST Analysis
   • Porter’s Five Forces Analysis
   • Epidemiology
   • Robust Pipeline Analysis

4. Ankylosing Spondylitis Market, By Drug Type, 2021 – 2033, (USD Billion)

   • Introduction
     • Market Share Analysis, 2026 and 2033 (%)
     • Y-o-Y Growth Analysis, 2022– 2033
     • Segment Trends
   • Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
   • Disease-modifying Anti-rheumatic Drugs (DMARDs)
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
   • TNF Inhibitors
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
   • Corticosteroids
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
   • Others
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)

5. Ankylosing Spondylitis Market, By Route of Administration, 2021 – 2033, (USD Billion)

   • Introduction
     • Market Share Analysis, 2026 and 2033 (%)
     • Y-o-Y Growth Analysis, 2022– 2033
     • Segment Trends
   • Oral
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
   • Parenteral
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)

6. Ankylosing Spondylitis Market, By Distribution Channel, 2021 – 2033, (USD Billion)

   • Introduction
     • Market Share Analysis, 2026 and 2033 (%)
     • Y-o-Y Growth Analysis, 2022– 2033
     • Segment Trends
   • Hospital Pharmacies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
   • Retail Pharmacies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
   • Online Pharmacies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)

7. Ankylosing Spondylitis Market, By Region, 2021 – 2033, (USD Billion)

   • Introduction
     • Market Share Analysis, By Region, 2026 and 2033 (%)
     • Y-o-Y Growth Analysis, For Regions, 2022–2033
     • Regional Trends
   • North America
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Billion)
     • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Billion)
     • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)
     • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Billion)
       • U.S.
       • Canada
   • Latin America
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Billion)
     • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Billion)
     • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)
     • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Billion)
       • Brazil
       • Mexico
       • Argentina
       • Rest of Latin America
   • Europe
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Billion)
     • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Billion)
     • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)
     • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Billion)
       • U.K.
       • Germany
       • Italy
       • France
       • Spain
       • Russia
       • Rest of Europe
   • Asia Pacific
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Billion)
     • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Billion)
     • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)
     • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Billion)
       • China
       • India
       • Japan
       • ASEAN
       • Australia
       • South Korea
       • Rest of Asia Pacific
   • Middle East
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Billion)
     • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Billion)
     • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)
     • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Billion)
       • GCC
       • Israel
       • Rest of Middle East
   • Africa
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Billion)
     • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Billion)
     • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)
     • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 – 2033, (USD Billion)
       • North Africa
       • Central Africa
       • South Africa

8. Competitive Landscape

   • Heat Map Analysis
   • Market Share Analysis
   • Company Profile
     • Amgen Inc.
       • Company Highlights
       • Product Portfolio
       • Financial Performance
       • Recent Highlights
       • Market Strategies
     • AbbVie Inc.
       • Company Highlights
       • Product Portfolio
       • Financial Performance
       • Recent Highlights
       • Market Strategies
     • Pfizer Inc.
       • Company Highlights
       • Product Portfolio
       • Financial Performance
       • Recent Highlights
       • Market Strategies
     • Novartis AG
       • Company Highlights
       • Product Portfolio
       • Financial Performance
       • Recent Highlights
       • Market Strategies
     • Bristol-Myers Squibb Company
       • Company Highlights
       • Product Portfolio
       • Financial Performance
       • Recent Highlights
       • Market Strategies
     • CELGENE CORPORATION
       • Company Highlights
       • Product Portfolio
       • Financial Performance
       • Recent Highlights
       • Market Strategies
     • Eli Lilly and Company
       • Company Highlights
       • Product Portfolio
       • Financial Performance
       • Recent Highlights
       • Market Strategies
     • Cipla Inc.
       • Company Highlights
       • Product Portfolio
       • Financial Performance
       • Recent Highlights
       • Market Strategies
     • Emcure Pharmaceuticals
       • Company Highlights
       • Product Portfolio
       • Financial Performance
       • Recent Highlights
       • Market Strategies
     • Torrent Pharmaceuticals Ltd.
       • Company Highlights
       • Product Portfolio
       • Financial Performance
       • Recent Highlights
       • Market Strategies
     • UCB S.A.
       • Company Highlights
       • Product Portfolio
       • Financial Performance
       • Recent Highlights
       • Market Strategies
     • Suzhou Zelgen Biopharmaceuticals Co., Ltd.
       • Company Highlights
       • Product Portfolio
       • Financial Performance
       • Recent Highlights
       • Market Strategies
     • HENGRUI USA
       • Company Highlights
       • Product Portfolio
       • Financial Performance
       • Recent Highlights
       • Market Strategies
     • Johnson & Johnson Services, Inc.
       • Company Highlights
       • Product Portfolio
       • Financial Performance
       • Recent Highlights
       • Market Strategies
   • Analyst Views

9. Section

   • References
   • Research Methodology
   • About Us